Stock Research for AVXL

AVXL

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AVXL Stock Chart & Research Data

The AVXL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AVXL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AVXL Due diligence Resources & Stock Charts

The AVXL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AVXL Detailed Price Forecast - CNN Money CNN View AVXL Detailed Summary - Google Finance
Yahoo View AVXL Detailed Summary - Yahoo! Finance Zacks View AVXL Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AVXL Trends & Analysis - Trade-Ideas Barrons View AVXL Major Holders - Barrons
NASDAQ View AVXL Call Transcripts - NASDAQ Seeking View AVXL Breaking News & Analysis - Seeking Alpha
Spotlight View AVXL Annual Report - CompanySpotlight.com OTC Report View AVXL OTC Short Report - OTCShortReport.com
TradeKing View AVXL Fundamentals - TradeKing Charts View AVXL SEC Filings - Bar Chart
WSJ View Historical Prices for AVXL - The WSJ Morningstar View Performance/Total Return for AVXL - Morningstar
MarketWatch View the Analyst Estimates for AVXL - MarketWatch CNBC View the Earnings History for AVXL - CNBC
StockMarketWatch View the AVXL Earnings - StockMarketWatch MacroAxis View AVXL Buy or Sell Recommendations - MacroAxis
Bullish View the AVXL Bullish Patterns - American Bulls Short Pains View AVXL Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AVXL Stock Mentions - StockTwits PennyStocks View AVXL Stock Mentions - PennyStockTweets
Twitter View AVXL Stock Mentions - Twitter Invest Hub View AVXL Investment Forum News - Investor Hub
Yahoo View AVXL Stock Mentions - Yahoo! Message Board Seeking Alpha View AVXL Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AVXL - SECform4.com Insider Cow View Insider Transactions for AVXL - Insider Cow
CNBC View AVXL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AVXL - OTC Markets
Yahoo View Insider Transactions for AVXL - Yahoo! Finance NASDAQ View Institutional Holdings for AVXL - NASDAQ


Stock Charts

FinViz View AVXL Stock Insight & Charts - FinViz.com StockCharts View AVXL Investment Charts - StockCharts.com
BarChart View AVXL Stock Overview & Charts - BarChart Trading View View AVXL User Generated Charts - Trading View




Latest Financial News for AVXL


Edited Transcript of AVXL earnings conference call or presentation 10-May-18 8:30pm GMT
Posted on Wednesday July 11, 2018

Q2 2018 Anavex Life Sciences Corp Earnings Call


Anavex Life Sciences Receives Approval to Initiate Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Parkinson’s Disease Dementia
Posted on Monday July 09, 2018

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, today announced that the Company has received approval from the Spanish Agency for Medicinal Products and Medical Devices (AEMPS), to initiate its Phase 2, double-blind, placebo-controlled 14-week trial of the safety and efficacy of ANAVEX®2-73 for the treatment of Parkinson’s disease dementia (PDD). The Phase 2 study is scheduled to initiate enrollment of approximately 120 patients, randomized 1:1:1 to two different ANAVEX®2-73 doses or placebo, within the next few months, in up to 24 clinical study sites.


Today’s Research Reports on Stocks to Watch: Anavex Life Sciences and Juniper Pharmaceuticals
Posted on Wednesday July 04, 2018

NEW YORK, NY / ACCESSWIRE / July 4, 2018 / Health stocks Anavex Life Sciences Corp. and Juniper Pharmaceuticals were both exploding in Tuesday trading on positive developments. Anavex announced it has ...


Why Anavex Life Sciences Stock Is Rising Today
Posted on Tuesday July 03, 2018

Today, Anavex Life Sciences (AVXL) announced approval from the Australian Human Research Ethics Committee to initiate its Phase 2b/3 trial evaluating investigational therapy ANAVEX2-73 in early Alzheimers’ disease. Avanex Life Sciences plans to initiate Phase 2 programs evaluating ANAVEX2-73 in Rett syndrome and Parkinson’s disease indications in H2 2018.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.